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Summary 
The requirement for target cell nuclei in the two apoptotic death pathways used by cytotoxic 
lymphocytes was tested using model effector systems in which the granzyme and Fas pathways 
of target damage are isolated. Mast cell tumors expressing granzymes A  and B in addition to 
cytolysin/perforin lysed tumor target cells about 10-fold more efficiently than comparable effector 
cells without granzymes. Enucleated cytoplast targets derived from these cells were also lysed 
with a similar 10-fold effect of granzymes. In contrast to cytoplasts, effector granzyme expression 
did not influence lysis of red cell targets. The Fas pathway was assessed using the sdected cytotoxic 
T  lymphocyte hybridoma subline d11S, which lysed target cells expressing Fas but not those 
lacking Fas. Similarly, cytoplasts derived from Fas + but not Fas-  calls were also readily lysed 
by these effector cells. Thus, neither the nucleus itsdf nor the characteristic apoptotic nuclear 
damage associated  with the two major cell death pathways used by cytotoxic lymphocytes are 
required for cell death per se. 
I 
t has recently become clear that cytotoxic lymphocytes in- 
flict lethal damage on target cells in vitro via two distinct 
mechanisms that involve granule exocytosis or Fas (1-4). Both 
mechanisms induce cell death within a few hours, and after 
the effector cells are fully activated, there is no requirement 
for protein or RNA synthesis. The dying cells generally dis- 
play apoptotic features including membrane blebbing,  nu- 
clear chromatin condensation, and DNA fragmentation (5-8). 
Although such apoptotic nuclear damage is a hallmark of 
this type of cell death, its functional role in the cell death 
pathway has been unclear. While some schemes for apop- 
totic death have included it in the sequence of events leading 
to death (9, 10), recent studies have indicated that enucleated 
cytoplasts die in response to growth factor withdrawal and 
antibody-mediated cross-linking of the Fas antigen (11, 12). 
We have recently developed model systems that isolate each 
of the cytotoxic lymphocyte  death pathways so that their prop- 
erties can be studied independently. For the granule exocy- 
tosis pathway, the mast cell tumor line RBL has been trans- 
fected so  that  it  expresses  the  CTL  lymphocyte granule 
components cytolysin/perforin, as well as the serine proteases 
granzyme A and B (8). When all three of these are expressed, 
RBL transfectants exhibit potent cytotoxic activity, with the 
granzymes required both for the apoptotic character of target 
death and for the potent cytolytic activity. For the Fas cyto- 
toxicity pathway, we have developed a selected CTL hybridoma 
line, d11S, which kills only Fas-bearing target cells after acti- 
vation by PMA and ionomycin (13). This activation has been 
shown to result in upregulation of the Fas ligand in these 
cells, allowing cross-linking of Fas antigen on the target calls 
and leading to their death (14). 
Using these two effector systems, we show here that both 
lymphocyte cytotoxicity pathways operate efficiently with 
enudeated target cells. Thus, the prominent nuclear damage 
accompanying death by both these pathways is not required 
for call death, as measured by membrane integrity. 
Materials and Methods 
Cells.  The preparation and properties of RBL mast cell tumor 
cells lines transfected  with either cytolysin  alone (RBbcy) or a com- 
bination of cytolysin, granzyme A, and granzyme B (RBL-cy-gza- 
gzb) have been previously described (8). The d11S hybridoma line 
using  the Fas cytotoxicity pathway exclusively was derived by 
recloning the dl0S line described previously (13, 15). d11S effector 
cells were preactivated with a 3-h incubation with 5 ng/ml PMA 
and 3/zg/ml ionomycin before the cytotoxicity assay. 
Cytoplast Preparation.  Cytoplasts  were prepared from target cells 
using the standard technique (16) with the modified Ficoll concen- 
trations described by Ojcius et al. (17). The purity of cytoplasts 
was monitored by staining with 5 ~g/ml HOECFIST 33342 and 
examination in the fluorescence microscope. The cytoplast prepa- 
rations used in this study all had purities of >98% and most were 
>99%.  They were loaded with NazSlCrO7 by the standard tech- 
nique and showed spontaneous release rates very similar to those 
of the cells from which they were derived. 
Cytotoxicity Assays.  Target  cells were prepulsed with nsI-UdR 
to label DNA and were then labeled with SlCr as described (18). 
All assays were incubated for 4 h at 37~  before harvest. 12SI-DNA 
release was measured after treatment with Triton X-100 (18). 
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Cytoplast preparations were >98% free of nuclei and ap- 
proximately one-half the diameter of the tumor cells used 
(Fig. 1, A and B). A functional demonstration that these prepa- 
rations are enucleated was provided by the effect of etopo- 
side, a cytotoxic inhibitor of the nuclear enyzme DNA topo- 
isomerase II (19) (Fig.  1 C). In contrast to intact cells, which 
showed  both  SlCr  and  125I-DNA  release  in  response  to 
etoposide, cytoplasts were completely resistant to this agent. 
Target cell damage via the granule exocytosis cytotoxicity 
pathway would seem to occur by both membrane damage 
caused by cytolysin/perforin and by internal damage caused 
by the entry of granzymes into the target cytoplasm (20). 
The RBL transfectant expressing cytolysin/perforin (RBL- 
cy) allows assessment of the former, while the contribution 
of granzymes can be assessed by comparing RBL-cy with 
triple transfectants expressing a combination of granzymes 
A and B as well as cytolysin (RBL-cy-gza-gzb). The mRNA 
expression levels of these granule components in the RBL 
transfectants used in this study were within a factor of three 
of the expression levels in our reference  cloned CTL line (Fig. 
2 A). Previous results indicated that RBL-cy, which showed 
a potent IgE-dependent ability to lyse red cell targets, were 
only marginally cytotoxic toward tumor targets (8, 21). Fig. 
2, C and D, confirms this result and further shows that ex- 
pression of granzymes A  and B confers a ",~10-fold increase 
in cytolytic activity, as seen by comparing the KBL-cy SlCr 
release titration curve with that of RBL-cy-gza-gzb. In addi- 
tion, granzyme expression was accompanied by a dramatic 
increase in the levels of target DNA release  accompanying 
lysis, thus implicating granzymes in both membrane damage 
and apoptotic nuclear damage associated with this pathway. 
RBL granzyme expression was also  correlated with apop- 
totic target nuclear morphology (8). Fig. 2, E and F, shows 
that for two standard tumor target cell lines, cytoplast lysis 
by each type of RBL transfectant was similar to that of the 
parental intact cells. In particular, the '~10-fold difference be- 
tween the RBL-cy and RBL-cy-gza-gzb transfectants was 
largely maintained in each case. This result with cytoplasts 
was particularly striking in comparison with lysis of red cell 
targets (Fig.  2 B),  which were potently lysed equally well 
by RBL-CY and RBL-cy-gza-gzb. Thus, the cytotoxic effect 
of granzymes, which does not operate in red cells that are 
easily killed by membrane damage, operates equally well in 
the presence or absence of nuclei. 
Cytolysin/perforin is necessary for target cell damage by 
the granule exocytosis pathway as shown by the gene knockout 
results (22) as well as by the lack of  cytotoxicity of granzyme- 
transfected RBL  lacking cytolysin/perforin (8,  23).  While 
it is required for measurable cytotoxicity by this pathway, 
the ability of tumor cells to repair membrane damage (24) 
means that this alone is an inefl~dent killing mechanism. This 
is reflected in the modest cytolytic abilities of RBL-cy clones 
(reference  8 and Fig. 2, C and D) as well as the 10-fold greater 
sensitivity of red cells compared with tumor cells when soluble 
cytolysin/perforin is added to the medium (25).  Recent evb 
dence showing blocking of cytotoxity by loading the target 
cytoplasm with the granzyme inhibitor aprotinin strongly 
suggests  that  the granzymes need to enter the target cell 
cytoplasm to participate in the cytotoxic process (20).  While 
the nature of the cytoplasmic substrates of these proteases 
remains to be defined, we have recently described evidence 
for a synergistic interaction between granzymes A and B (8). 
Figure  1.  Cytoplast characterization.  P815 cells (A) and cytoplasts (B) stained with the fluorescent  DNA-binding dye HOECHST 33342 (blue) 
using combination  phase-fluorescence  optics. A rare  contaminant  karyoplast  was chosen  for illustration in B. (C) Cytotoxic  effect  of etoposide  on ED4 
cells (filled triangles) versus EL-4 cytoplasts  (open triangles). After labeling, these targets were incubated 18 h with the indicated  final concentrations 
of etoposide, and the release of SlCr (solid lines) or 12SI-DNA  (dotted line) was measured. 
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cytophsts. (A) mRNA expression of  lymphocyte  granule 
components in RBL transfectants. Northern blots were 
prepared from separate RNA preparations from four 
individual RBbcy clones and two individual RBbcy- 
gza-gzb clones and probed with the respective granule 
component probes as well as 3-actin. Phosphorimager 
analyses of these blots were normalized to/3-actin and 
then expressed as a percentage of the level of reference 
mouse allo-CTL clone TIM 448. Data are expressed as 
the mean expression levels of the clones of each type; 
the error bars represent SEM. B shows the equal cyto- 
toxicity of RBL-cy  (circles) and RBL-cy-gza-gzb  (squares) 
on human red cell targets. (C-F) Comparisons of the 
cytotoxicity of RBbcy (circles) and  RBL-cy-gza-gzb 
(squares) on EL-4  thymoma target cells (C), P815 masto- 
cytoma target calls (D), cytoplasts from Eb4 (E), or 
cytoplasts from P815 (F). The data show release of stCr 
(solid lines) or t2SI-DNA  (dashed lines) after 4 h of in- 
cubation, with error bars showing SEM. (B-F) Data 
for each type of RBL transfectant is the mean marker 
release using the same four RBbcy and two RBL-cy- 
gza-gzb clones described in Fig. 1. Additional controls 
with tumor cell targets treated with cytochalasin  B but 
not spun in the Ficoll gradient showed identical cyto- 
toxicity  to  nontreated tumor  cell targets (data not 
shown). 
One candidate  substrate  is  cdc2 kinase,  which was  shown 
to be activated by a granzyme B-like NK cell granzyme (6), 
thus precipitating a "mitotic catastrophe" giving rise to the 
prototypical apoptotic nuclear damage.  However, these ex- 
periments did not address the issue of whether  this nuclear 
damage was part  of the chain  of events  giving rise  to cell 
death or whether it represents  a separate branch of destruc- 
tive events triggered by cytoplasmic mediators such as those 
recently described (26, 27). Our experiments argue strongly 
in favor of the latter interpretation,  but they do not rule out 
a role for cdc2 kinase in target cell death,  since this enzyme 
may phosphorylate nonnuclear  proteins. 
We have used a similar approach to assess whether the nu- 
cleus is required for target cell death caused by Fas when it 
is cross-linked by Fas ligand on the surface of effector cells. 
As can be seen from Fig. 3 A, d11S kills Fas-transfected L1210 
cells but not the parental L1210 line,  which expresses little 
or no Fas  (13).  This death is apoptotic,  as seen by prelytic 
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Figure 3.  The Fas death pathway operates in cyto- 
plasts. (.4 and B) Cytotoxicity using d11S effectors  on 
L1210-Fas  + targets (circles  and triangles) and L1210-Fas- 
targets (squares). The  triangles represent L1210-Fas  + 
cells, which were treated with cytochalasin  B but not 
spun in the Ficoll gradient (followed  by the same wash 
as was used for the cytoplasts). A shows a 4-h assay, 
while B shows the kinetics using an effector/target  ratio 
of 3.3. (C and D) 4-h experiments similar to A, except 
that the target cells were 2B4 T hybridoma cells (C) 
and Eb4-Fas + cells D. d11S cells showed no detectable 
cytotoxicity  on EL-4-Fas- cells (data not shown). In all 
panels, filled symbols are intact cells and open symbols 
are cytoplasts; solid lines show sxCr release and dashed 
lines show *zSI-DNA  release. 
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Fig. 3 B). When cytoplasts from L1210-Fas and L1210 tumor 
cells were tested for their ability to be lysed by dllS, cytoplasts 
from the former but not the latter were lysed by dllS with 
titration curves parallel to those with intact tumor ceils (Fig. 
3 A). With cytoplast targets, roughly threefold more dllS 
cells were required to achieve levels of lysis comparable to 
that of the intact cells.  The kinetics of cytoplast lysis was 
not significantly different from that of intact cells (Fig. 3 B). 
Cytoplasts from other Fas-bearing tumor cells showed very 
similar results, as shown in Fig. 3, C and D. In these cases, 
dllS also caused lysis of Fas-bearing cytoplasts with similarly 
2-3 x  shifted dose-response curves compared with the pa- 
rental Fas-bearing tumor cells. This difference between cyto- 
plasts and cells was not attributable to cytochalasin B treat- 
ment since L1210-Fas cells treated with cytochalasin B but 
not subjected to the gravitational field to produce cytoplasts 
were not different from untreated cells (Fig.  3 A). The less 
efficient lysis of Fas-bearing cytoplasts may suggest that the 
nucleus, while not required, can influence cell death in this 
case. However, other differences between cytoplasts and their 
parental cells (such as the smaller size of cytoplasts) may also 
be responsible. These results are similar to those of a recent 
report  showing  that  anti-Fas  antibody induces apoptotic 
morphology changes and inhibition of mitochondrial 3-(4, 
5-dimethylthiazol-2-yl)-2,  5-dimethyltetrazolium bromide 
reduction in cytoplasts (12); in our experiments, Fas cross- 
linking was provided by effector-bound Fas ligand. 
These experiments show that for both defined cytotoxic 
lymphocyte-mediated death pathways, the nucleus is not re- 
quired for target cell death. While these death pathways are 
typically apoptotic in that they result in target death accom- 
panied by characteristic nuclear damage, they are consider- 
ably more rapid than most examples of programmed cell death. 
Earlier results showing that CTL lysis of target cytoplasts 
was similar (28) or considerably less efficient (29) than intact 
target cells are difficult to interpret because of the multiple 
mediators used by CTL. 
It has generally been assumed that the various examples 
of apoptotic programmed cell death share mechanistic steps. 
Since the most readily measurable apoptotic death features 
are nuclear, and since cells cannot survive for a long time 
without nuclear gene transcription, it has been tempting to 
consider nuclear damage as part of such a widely shared cell 
death pathway. The evidence presented here provides examples 
of cell death pathways that do not directly require the nu- 
cleus,  even though the latter undergoes apoptotic damage; 
these are similar to the cases of apoptotic cell death from in- 
sulin withdrawal or treatment with staurosporine or mena- 
dione, which were also found to occur in cytoplasts (11, 12). 
These data raise the possibility that apoptotic nuclear damage 
may be an epiphenomenon with respect to cell death gener- 
ally, although it is quite possible that other examples of slower 
apoptotic death may be a consequence of nuclear damage. 
It can also be argued that target cell DNA degradation is 
relevant to the overall biological function of cytotoxic lym- 
phocytes, which is elimination of intracellular microorganisms, 
particularly viruses whose nucleic adds may be infectious (30). 
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